Deferoxamine-mediated up-regulation of HIF-1α prevents dopaminergic neuronal death via the activation of MAPK family proteins in MPTP-treated mice
- 1 June 2016
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 280, 13-23
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of China (81430025, 81301102)
- Basic Scientific Research Fund of Northeastern University (N120820001, N130120002, N142004003)
- Innovation Team Project of the Department of Education of Liaoning Province (LT2015010)
This publication has 68 references indexed in Scilit:
- Iron Chelators and Antioxidants Regenerate Neuritic Tree and Nigrostriatal Fibers of MPP+/MPTP-Lesioned Dopaminergic NeuronsPLOS ONE, 2015
- Reversing multidrug resistance in hepatocellular carcinoma cells by inhibiting extracellular signal-regulated kinase/mitogen-activated protein kinase signaling pathway activityOncology Letters, 2014
- Therapeutics for Alzheimer's Disease Based on the Metal HypothesisNeurotherapeutics, 2008
- c-Jun NH2-Terminal Kinase Activation Contributes to Hypoxia-Inducible Factor 1α–Dependent P-Glycoprotein Expression in HypoxiaCancer Research, 2004
- Metal Chelation as a Potential Therapy for Alzheimer's DiseaseAnnals of the New York Academy of Sciences, 2000
- HIF-1-mediated activation of transferrin receptor gene transcription by iron chelationNucleic Acids Research, 1999
- A Quantitative Analysis of Isoferritins in Select Regions of Aged, Parkinsonian, and Alzheimer's Diseased BrainsJournal of Neurochemistry, 1995
- Role of iron and iron chelation in dopaminergic-induced neurodegeneration: Implication for Parkinson's diseaseAnnals of Neurology, 1992
- Intramuscular desferrioxamine in patients with Alzheimer's diseaseThe Lancet, 1991
- The Iron Chelator Desferrioxamine (Desferal) Retards 6‐Hydroxydopamine‐Induced Degeneration of Nigrostriatal Dopamine NeuronsJournal of Neurochemistry, 1991